Results 91 to 100 of about 39,881 (211)

A retrospective study on the effects of illness severity and atrial fibrillation on outcomes in the intensive care unit [PDF]

, 2013
Introduction: Atrial fibrillation (AF) is common in patients in the intensive care unit (ICU) and has been associated with worse outcomes. However, it is unclear whether AF itself adds to the risk of death or is merely a marker of illness severity ...
Kinsella, J., Quasim, T., Rankin, A.C., Riddell, L., Williams, C.   +4 more
core  

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. [PDF]

, 2017
The ENSURE-AF study (NCT 02072434) of anticoagulation for electrical cardioversion in nonvalvular atrial fibrillation (NVAF) showed comparable low rates of bleeding and thromboembolism between the edoxaban and the enoxaparin-warfarin treatment arms. This
Al-Saady, N, Banach, M, Ezekowitz, MD, Goette, A, Lip, GYH   +4 more
core   +2 more sources

Gynaecological Laparoscopy Surgery Complicated Into CO2 Embolism, Cardiac Arrest and Severe ARDS Requiring ECMO Therapy

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We report a case of CO2 embolism complicated by severe ARDS with refractory hypoxia requiring extracorporeal membrane oxygenation (ECMO) therapy, which resulted in a favourable outcome. ABSTRACT Laparoscopic surgeries have revolutionised surgical practice due to their advantages, including minimal invasiveness, fewer postoperative complications ...
Jawdat Alali, Umm  E. Amara, Malek Abusannuga, Umme Nashrah, Firdous Ummunnisa, Nissar Shaikh   +5 more
wiley   +1 more source

Clinical and Laboratory Impact of Postpartum Enoxaparin Prophylaxis After Vaginal Delivery: A Retrospective Cohort Study

Cam & Sakura Medical Journal
Objective: To assess the clinical and laboratory effects of prophylactic enoxaparin use after vaginal delivery on bleeding, wound complications, and hematological parameters.
Emrah Dağdeviren, Ali Selçuk Yeniocak, Can Tercan, Şeyda Büyük, Nisa Sarı, Elif Ataseven, Yücel Kaya, Gazi Güner   +7 more
doaj   +1 more source

Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review [PDF]

, 2012
INTRODUCTION: Despite evidence-based guidelines for venous thromboembolism prevention, substantial variability is found in practice. Many economic evaluations of new drugs for thromboembolism prevention do not occur prospectively with efficacy studies ...
Deborah J Cook, Robert A Fowler, Ruxandra Pinto, Subarna Thirugnanam, William H Geerts   +4 more
core   +1 more source

Colorectal Cancer Complicated by Pulmonary Embolism and Potential Takotsubo Cardiomyopathy in a Person With Cystic Fibrosis: Diagnostic and Management Considerations

Respirology Case Reports, Volume 14, Issue 5, May 2026.
We describe a complex case of pulmonary embolism and dilated cardiomyopathy in a person with cystic fibrosis. These late complications occurred following laparoscopic left hemicolectomy for colonic adenocarcinoma. This case highlights the complexities of evaluating breathlessness in severe lung disease, and the management challenges that arise as life ...
Laura Frederiksen, James Brown, Vanessa Moore, David W. Reid   +3 more
wiley   +1 more source

Update on the Pharmacological Actions of Enoxaparin in Nonsurgical Patients

Medicina
Low-molecular-weight heparins are a class of drugs derived from the enzymatic depolymerization of unfractionated heparin that includes enoxaparin. Several studies have been performed on enoxaparin in recent years, in particular for the prevention and ...
Egidio Imbalzano, Luana Orlando, Giuseppe Dattilo, Marianna Gigliotti De Fazio, Giuseppe Camporese, Vincenzo Russo, Alessandro Perrella, Francesca Futura Bernardi, Pierpaolo Di Micco   +8 more
doaj   +1 more source

A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency [PDF]

, 2015
Purpose Although therapeutic dosages of most low-molecular-weight heparins (LMWHs) are known to accumulate in patients with renal insufficiency, for the lower prophylactic dosages this has not been clearly proven.

core   +1 more source

Impact of Disease‐Specific Treatment and Non‐Selective Beta Blockers on Risk of PVT in Cirrhotic Patients With HCV or PBC

Liver International, Volume 46, Issue 5, May 2026.
ABSTRACT Background Portal vein thrombosis (PVT) is a common sequela of cirrhosis. Despite regression of fibrosis/cirrhosis observed among some patients after disease‐specific treatment, few studies have considered the role of treatment and response on risk of PVT among patients with cirrhosis across different liver disease states.
Humberto C. Gonzalez, Stuart C. Gordon, Sheri Trudeau, Trueman Wu, Lora Rupp, Christina Melkonian, Mark A. Schmidt, Yihe G. Daida, Amandeep K. Sahota, Christopher L. Bowlus, Mei Lu   +10 more
wiley   +1 more source

Apixaban Reduces Hospitalizations in Patients With Venous Thromboembolism: An Analysis of the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) Trial

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2015
Background In the Apixaban for the Initial Management of Pulmonary Embolism and Deep‐Vein Thrombosis as First‐Line Therapy (AMPLIFY) trial, apixaban was noninferior to enoxaparin/warfarin in preventing recurrent symptomatic venous thromboembolism (VTE ...
Xianchen Liu, Margot Johnson, Jack Mardekian, Hemant Phatak, John Thompson, Alexander T. Cohen   +5 more
doaj   +1 more source